Reagents & Consumables Segment based on the Product Drives dPCR Market Growth
According to our new research study named "dPCR Market Forecast to 2031 – Global Analysis – by Product, Application, and End User," the market was valued at US$ 7.52 billion in 2024 and is projected to reach US$ 14.34 billion by 2031; it is expected to register a CAGR of 9.4% during 2025–2031. The demand for highly sensitive and accurate nucleic acid detection, expanding applications in clinical diagnostics and personalized medicine, and rising advancements in dPCR Technology and Automation are key factors driving the dPCR market size. However, high cost of instrumentation and consumables hinder market growth. The growth in cell & gene therapy quality control is projected to bring new dPCR market trends in the coming years.
dPCR can measure genetic material very accurately and detect rare genetic targets, which is a key reason for its market growth. This accuracy is especially important in oncology, where early detection of circulating tumor DNA (ctDNA) helps with cancer diagnosis and monitoring. For example, the American Cancer Society reported about 1.9 million new cancer cases in the US in 2022, showing the need for better diagnostic tools. In 2023, the European Cancer Information System (ECIS) projected over 2.7 million new cancer cases in the European Union, highlighting this demand. New products such as Bio-Rad Laboratories' QX ONE Droplet Digital PCR System, launched in 2022, offer better multiplexing and automation, meeting the need for sensitive, high-throughput detection in clinical and research labs. The increase in infectious diseases, including tracking SARS-CoV-2 variants, also requires sensitive methods for detecting pathogens and measuring viral loads, which dPCR provides.
dPCR Market, by Region, 2024 (%)
dPCR Market Size, Share & Demand Insights by 2031
Download Free SampledPCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Application, and Forensic Application), End user (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organizations)
Source: The Insight Partners Analysis
DPCR Market Analysis Based on Segmental Evaluation:
Based on product, the dPCR market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest dPCR market share in 2024. The reagents and consumables segment is growing because dPCR testing requires repeated purchases of kits and enzymes, driven by ongoing infectious disease diagnostics and surveillance needs.
Based on applications, the dPCR market is segmented into research, clinical, and forensic. The therapeutic applications segment held a significant dPCR market share in 2024. The clinical application segment is growing due to rising demand for accurate molecular diagnostics in infectious diseases, oncology, genetic testing, and routine hospital laboratory testing worldwide. The clinical application segment is subsegmented as oncology testing, blood screening, infectious disease testing, and others.
Based on end user, the dPCR market is divided into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, research laboratories and academic institutes, forensic laboratories, and clinical research organizations. The hospitals and clinics segment held the largest dPCR market share in 2024. Hospitals and diagnostic centers dominate the dPCR market as they perform high-volume clinical diagnostics for infectious and genetic diseases, have advanced lab infrastructure, and require fast, accurate test results for patient care and treatment decisions.
The geographical scope of the dPCR market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. According to the dPCR market analysis, North America led the market in 2024 with the highest revenue share. This was due to advanced healthcare systems, major research and development investments, high demand for molecular diagnostics, and many top biotech and diagnostic companies. Europe and Asia Pacific also saw steady growth in clinical, research, and biopharmaceutical areas.
The dPCR market outlook indicates that Asia Pacific is expected to register the fastest growth in the coming years, supported by expanding healthcare access, increasing adoption of molecular diagnostics, rising government healthcare investments, and growing laboratory capacity. This shift in regional momentum presents significant opportunities for dPCR manufacturers to expand operations, strengthen distribution networks, and pursue strategic partnerships to capitalize on the rapidly growing demand in emerging markets.
Abbott; Qiagen; Bio-Rad Laboratories Inc.; Agilent Technologies, Inc.; Thermo Fisher Scientific, Inc.; GE Healthcare, bioMérieux; F. Hoffmann-La Roche Ltd, Takara Bio Inc; and Stilla Technologies Holding AG are among the leading companies profiled in the dPCR market report.
Geographically, the market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com